Discover
IKT
Inhibikase Therapeutics, Inc.
2.46
1 x 2.40
6 x 2.50
bid
ask
-
0.02
0.61%
09:40 AM
timesize
| Ytd | 19.76% | |
| 1y | 71.68% |
2.42
day range
2.48
1.33
52 week range
2.53
| Open | 2.42 | Prev Close | 2.47 | Low | 2.42 | High | 2.48 | Mkt Cap | 324.14M |
| Vol | 10.50K | Avg Vol | 856.01K | EPS | -0.43 | P/E | -5.71 | Forward P/E | -11.84 |
| Beta | 1.12 | Short Ratio | 0.17 | Inst. Own | 11.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-12 | 50-d Avg | 1.98 | 200-d Avg | 1.79 | 1yr Est | 7.00 |
IKT News
benzinga.com
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Ma
US stock futures up, Nasdaq 100 gains 1%. Danaher Corp (DHR) shares fall 10.1% in pre-market trading
benzinga.com
Inhibikase Therapeutics Sells 25M Common Shares To RA Capital Management Through At-The-Market Facil
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-s
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 275 companies made new 52-week lows.